Author: Ken Dropiewski

Canon Medical Receives FDA Clearance for Aquilion ONE / PRISM Edition, Enabling Deep Learning Spectral Capabilities for Routine Use

Spectral CT with Advanced intelligent Clear-IQ Engine (AiCE) Empowers Physicians with Deep Intelligence to Enable Routine Confident Diagnoses TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical Systems USA, Inc. has received 510(k) clearance for the Aquilion ONE / PRISM Edition, enabling Deep Learning Spectral capabilities that allow for more routine spectral imaging. Designed for deep […]

Premier Inc. ProvideGx™ Program Partners with Pfizer Inc. to Provide Corvert® and Vincristine to Providers

CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, has partnered with Pfizer Inc. to supply Corvert® (ibutilide fumarate injection) and Vincristine Sulfate Injection, USP, to healthcare providers, to help stabilize the long-term supply of two vital medications for its members. Corvert is an anti-arrhythmic heart medication used to treat […]

Cerus Endovascular Receives CE Mark Approval for its Contour Neurovascular System™, Designed to Treat Intracranial Aneurysms

Commercial Sales Across European Union Expected to Begin in Second Quarter of 2020 FREMONT, Calif. and OXFORD, England, Feb. 18, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its lead product, the Contour Neurovascular System™, for the treatment of […]

The Latest in Pediatric Heart Disease: Benefits of Skin-to-Skin Care, Nurse-Initiated PIV Training and Improving Cholesterol Screening in High-Risk Patients

–CHOP’s Cardiology 2020 Conference Research Highlights– PHILADELPHIA, Feb. 17, 2020 /PRNewswire/ — Experts in pediatric heart disease from across the country shared the latest findings from their research at a large national conference hosted by the Cardiac Center at Children’s Hospital of Philadelphia (CHOP). The 23rd Annual Update on Pediatric and Congenital Cardiovascular Disease, “Vision 20/20: Lessons from […]

Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity

– New Gallant™ high voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity designed to help doctors tailor therapy to a patient’s unique clinical needs – Gallant ICD and CRT-D devices feature a more comfortable design, preferred by patients without compromising on battery longevity or high-voltage […]

The Biobeat Wearable Wristwatch and Patch Receive CE Mark Approval for Non-invasive Cuffless Monitoring of Blood Pressure, as Well as Cardiac Output, Stroke Volume, Pulse and Saturation

TEL AVIV, Israel, Feb. 18, 2020 /PRNewswire/ — Biobeat, a bio-medical technology company developing advanced sensing and remote monitoring solutions for patients, received CE Mark approval for its patch and wristwatch for measurement of blood pressure, cardiac output, stroke volume, blood oxygenation and heart rate in hospitals, clinics, long-term care and at home. […]

Acutus Medical Secures FDA Clearance, CE Mark for SuperMap™ and Announces First Procedures in U.S. and Initial Experience in EU

Breakthrough Technology Enables Super-Fast Electrical Mapping and Re-Mapping of the Entire Heart Chamber – Leading to Rapid, Efficient and Individualized Ablation Strategies CARLSBAD, Calif., Feb. 18, 2020 /PRNewswire/ — Acutus Medical today announced FDA clearance and CE Mark of SuperMap – a revolutionary addition to its AcQMap 3D Imaging and Mapping System. SuperMap is […]